Protagenic Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PTIX Nasdaq 2836 www.protagenic.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Protagenic Therapeutics, Inc.

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity - May 21st, 2025 7:15 am
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders - May 19th, 2025 5:43 am
Biotech Alert: Searches spiking for these stocks today - May 10th, 2025 9:55 am
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split - Apr 29th, 2025 2:00 pm
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - Nov 5th, 2024 6:12 am
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - Oct 29th, 2024 8:27 am